Rotavirus vaccines: safety, efficacy and public health impact. - Wikidata - awgldk - TriplyDB

Rotavirus vaccines: safety, efficacy and public health impact.

Rotavirus vaccines: safety, efficacy and public health impact.

http://www.wikidata.org/entity/Q45165657

about

Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model.Lactobacilli and bifidobacteria promote immune homeostasis by modulating innate immune responses to human rotavirus in neonatal gnotobiotic pigs.Vitamin A deficiency impairs adaptive B and T cell responses to a prototype monovalent attenuated human rotavirus vaccine and virulent human rotavirus challenge in a gnotobiotic piglet model Diversity and relationships of cocirculating modern human rotaviruses revealed using large-scale comparative genomics Comparative genomic analysis of genogroup 1 (Wa-like) rotaviruses circulating in the USA, 2006-2009 Probiotics and colostrum/milk differentially affect neonatal humoral immune responses to oral rotavirus vaccine.Effects of Escherichia coli Nissle 1917 and Ciprofloxacin on small intestinal epithelial cell mRNA expression in the neonatal piglet model of human rotavirus infection A reverse evidence of rotavirus vaccines impact.Escherichia coli Nissle 1917 protects gnotobiotic pigs against human rotavirus by modulating pDC and NK-cell responses.Expression of rotavirus VP6 protein: a comparison amongst Escherichia coli, Pichia pastoris and Hansenula polymorpha.Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland.The effect of routine rotavirus vaccination on healthcare utilization for diarrhea in US children.Preventive Effect of a Synbiotic Combination of Galacto- and Fructooligosaccharides Mixture With Bifidobacterium breve M-16V in a Model of Multiple Rotavirus Infections.

P2860

Q34060471-727A70CA-CCDA-4729-9ED7-E22E21C14B2D Q35009719-07B4C586-53E7-41BB-BBB8-3A01E19F7D9D Q35061582-7D8BA702-047F-40BD-92BC-00419C13642E Q36154960-B2ECC6BC-8518-4B80-847C-F4EF3DB93825 Q36206294-BF6BB39E-60E6-446C-8E64-D0D06461D77C Q36711360-6925A3E1-BB58-44B9-8ECE-2AC500185D07 Q37498366-4FFB2DF4-E318-42EC-AF72-37C13B0187AE Q37514769-A975CC44-6750-4947-8A60-2E96F559DCE5 Q40600252-B0057A0D-BE33-4B8B-93AB-2A396F48816C Q40973720-A9DAC201-D869-477D-A3E5-36D875091803 Q50876164-0AA5B620-DED9-45F5-8DE2-241F188A87CE Q53096855-D4CA899F-141F-4E48-8CD9-44CF75184136 Q55261664-99C7A428-334C-43C9-910C-80D9B57A3181

P2860

Rotavirus vaccines: safety, efficacy and public health impact.

http://www.wikidata.org/entity/Q45165657

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Rotavirus vaccines: safety, efficacy and public health impact.

@en

Rotavirus vaccines: safety, efficacy and public health impact.

@nl

type

label

Rotavirus vaccines: safety, efficacy and public health impact.

@en

Rotavirus vaccines: safety, efficacy and public health impact.

@nl

prefLabel

Rotavirus vaccines: safety, efficacy and public health impact.

@en

Rotavirus vaccines: safety, efficacy and public health impact.

@nl

P1433

Q45165657-AEEB9584-49D8-4A09-A018-98E404BB930A

P1476

Q45165657-8108FBAA-42CB-4453-A96F-92B671CA2BE1

P2093

Q45165657-135ED7A6-1681-43F7-A7F3-0ABF407CFF74

P2860

Q45165657-0ED313A8-2AE8-4A7C-8820-453345289B36

Q45165657-1DC00942-D41E-4A19-9EBF-A5D5DD9ADBAD

Q45165657-3A4603FC-9C52-457F-AEBF-A9B955CA6E1D

Q45165657-3D26E64E-9A3C-4492-8B59-CD110561A35C

Q45165657-4483780E-9DBC-464C-876D-D23F3476906A

Q45165657-4A5E1D79-B789-43AE-93FE-83E6FED1FAEF

Q45165657-4DE35409-0BB5-4FC4-A809-1642E9C80F27

Q45165657-59EE3653-30FD-48DA-A844-20C4BD2608A4

Q45165657-6AE06C0B-F363-43DC-A5FD-2216F130610D

Q45165657-850CA0CC-7C6F-4EAD-BADC-397E08FC1393

P304

Q45165657-71B03297-477F-4843-82EE-CBEB1FDD486A

P31

Q45165657-AC7C6E1D-0774-43D1-8412-5DC0CA190ACC

P356

Q45165657-EC90F5B3-4517-498D-B622-07768BE99B00

P407

Q45165657-923210CC-6716-46ED-B828-49CF34F6F189

P433

Q45165657-F73C95A0-FAF6-4249-8EC6-6BEEB0F8A0B5

P478

Q45165657-62D96D6F-8053-4A34-B11F-E9680811A19E

P577

Q45165657-EA11C11D-92F4-43EA-A440-C834E28F6FAA

P5875

Q45165657-1D053B0F-2540-44AD-8395-BB1BA689D7CC

P698

Q45165657-DAC7C225-35A0-45FB-82AA-557F62DDD501

P921

Q45165657-5FAE03C4-17CB-4A2B-BBF4-56D00C1DFDC4

P356

J.1365-2796.2011.02409.X

P1433

Journal of Internal Medicine

P1476

Rotavirus vaccines: safety, efficacy and public health impact.

@en

P2093

J Gray

http://www.w3.org/2001/XMLSchema#string

P2860

Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data.

Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.

Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006.

Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.

Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital.

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.

Rotavirus genotyping: keeping up with an evolving population of human rotaviruses.

Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.

P304

206-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2796.2011.02409.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

270

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51215045

http://www.w3.org/2001/XMLSchema#string

P698

21668823

http://www.w3.org/2001/XMLSchema#string

P921